Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of a Non-Steroidal Novel Treatment for Scalp Psoriasis

NCT01368887 is registered in ClinicalTrials.gov with DermiPsor, Ltd. as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of a Non-Steroidal Novel Treatment for Scalp Psoriasis
Lead sponsor
DermiPsor, Ltd.
Phase
Phase 2
Overall status
Suspended
Start date
April 30, 2013
Completion date
April 30, 2014
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.